InnoVein

San Carlos, United States

InnoVein develops a medical device designed to offer implants for valve replacement in the femoral vein.

$2.5M raised

Feb 2023

Venture - Series Unknown

Top Investors

National Science FoundationY CombinatorMassChallengeCreative Destruction Lab (CDL)Zoic Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has InnoVein raised?

InnoVein has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.

Who are InnoVein's investors?

InnoVein's investors include National Science Foundation, Y Combinator, MassChallenge, Creative Destruction Lab (CDL), Zoic Capital.

Where is InnoVein headquartered?

InnoVein is headquartered in San Carlos, United States.

What does InnoVein do?

InnoVein develops a medical device designed to offer implants for valve replacement in the femoral vein.

What stage is InnoVein at?

InnoVein is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 6, 2023.

MLA

"InnoVein — Funding & Investors." VCBacked, February 6, 2023, https://www.vcbacked.co/company/innovein. Accessed June 4, 2026.

APA

VCBacked. (2023). InnoVein — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/innovein

Wikipedia (cite web)

{{cite web |title=InnoVein — Funding & Investors |url=https://www.vcbacked.co/company/innovein |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 6, 2023.